PERIPARTUM CARDIOMYOPATHY: 10-YEAR CLINICAL FOLLOW-UP


DOI: https://dx.doi.org/10.18565/pharmateca.2018.6.80-83

V.A. Sergeeva (1), S.P. Eliseeva (2), E.V. Zhuravleva (1)

1 Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia; 2 Regional Clinical Hospital, Saratov, Russia
Background. Peripartum cardiomyopathy (PPCM) is one of the most severe forms of extragenital pathology, which often results in a fatal outcome. Actually, PPCM is variant of dilated cardiomyopathy, which develops in the last trimester of pregnancy and in the early postpartum period, leads to the development of congestive heart failure, and can be accompanied by thromboembolic complications and life-threatening rhythm disorders. Description of the clinical case. The article presents a 10-year clinical follow-up in the settings of the cardiological department of the female patient with PPCM, which managed to achieve stabilization of hemodynamics, reduction of the size of the heart cavities, increase in the myocardial contractility. The complexity of diagnosis and selection of adequate therapy are described. Conclusion. Each clinical experience in the management of patients with PPCM seems to be useful for developing a general concept of diagnostic and therapeutic approaches for this disease.

About the Autors


Corresponding author: V.А. Sergeeva – PhD, Teaching Assistant at the Department of Hospital Therapy of the Medical Faculty, Saratov State Medical University n.a. V.I. Razumovsky, Saratov, Russia; e-mail: viktoriasergeeva@mail.ru, ORCID: http://orcid.org/0000-0001-8737-4264


Similar Articles


Бионика Медиа